Persistent URL of this record https://hdl.handle.net/1887/95599
In Collections
This item can be found in the following collections:
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
- All authors
- Langlois, M.R.; Chapman, M.J.; Cobbaert, C.; Mora, S.; Remaley, A.T.; Ros, E.; Watts, G.F.; Boren, J.; Baum, H.; Bruckert, E.; Catapano, A.; Descamps, O.S.; Eckardstein, A. von; Kamstrup, P.R.; Kolovou, G.; Kronenberg, F.; Langsted, A.; Pulkki, K.; Rifai, N.; Sypniewska, G.; Wiklund, O.; Nordestgaard, B.G.; EAS; European Federation Clinical Ch
- Date
- 2018-07-31
- Journal
- Clinical Chemistry
- Volume
- 64
- Issue
- 7
- Pages
- 1006 - 1033